Susan Hasty, Publisher
Table of Contents . . . July 22nd, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in AIDS Weekly | Other Publications
AIDS and HIV Therapy - P-glycoprotein inhibitors can increase antiretroviral CNS delivery
Antiretrovial Therapy - Successful antiretroviral treatment has little effect on overall immune function
AIDS and HIV Pathogenesis - Noncytotoxic antiviral mechanisms contribute to persistent infection resistance
AIDS and HIV Therapy - Interleukin-7 increases risk of naive T-cell infection
AIDS and HIV Therapy - Isotretinoin has little impact on cervical cancer risk
Cachexia - Loss of lean body mass in HIV-infected men linked to immunological processes
AIDS Prevention - Greater prevention efforts could be cure for rising cost of HIV treatment
AIDS Vaccine - African program needs $233 million, WHO says
AIDS and HIV Coinfection - Epstein-Barr virus levels have limited prognostic utility
AIDS and HIV Therapy - Rapid viral resistance seen in response to fusion inhibitor treatment
AIDS and HIV Therapy - Zidovudine amino acid phosphoramidate monoesters improve pharmacokinetics
Diagnostics - Abbott, OraSure enter distribution agreement for OraQuick Rapid HIV-1 test
Epidemiology - African AIDS infection rates slightly down, according to new health ministry figures
Financing - MedMira closes $3.25 million private placement
Financing - The Immune Response Corp. completes $4 million private financing
HIV Prevention - USF/TGH site for national study testing HIV vaccine in healthy, uninfected volunteers
HIV Therapy - New boosted saquinavir regimen to treat HIV receives CPMP positive opinion in the E.U.
Infectious Disease - Scientists explore role of STDs, malaria, and TB in Africa AIDS epidemic
Sexually Transmitted Diseases - Europe becoming complacent over HIV prevention
Virology - Abbott to provide free HIV test to assist mother-to-child transmission prevention
Virology - ViroLogic, Pfizer, expand agreement to support new HIV drug discovery and development efforts
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.